N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines

Infection and Immunity

Volumn 72, Issue 8, 2004, Pages 4884-4887

  Baraldo, Karin ^a   Mori, Elena ^a   Bartoloni, Antonella ^b   Petracca, Roberto ^a   Giannozzi, Aldo ^b   Norelli, Francesco ^b   Rappuoli, Rino ^a   Grandi, Guido ^a   Del Giudice, Giuseppe ^a  

^a Research Center   (Italy)

^b Technology Development   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CARRIER PROTEIN; CD4 ANTIGEN; EPITOPE; MENINGOCOCCUS VACCINE; PROTEIN CRM197; PROTEIN N19; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONJUGATE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; DIPHTHERIA TOXIN; DRUG CARRIERS; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MICE; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS, SEROGROUP C; RECOMBINANT PROTEINS; VACCINES, CONJUGATE;

EID: 3342977787     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.8.4884-4887.2004     Document Type: Article

References (19)

1. Alexander, J., M. F. del Guercio, A. Maewal, L. Qiao, J. Fikes, R. W. Chesnut, J. Paulson, D. R. Bundle, S. DeFrees, and A. Sette. 2000. Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. J. Immunol. 164:1625-1633.
2. Balmer, P., and R. Borrow. 2004. Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev. Vaccines 3:77-87.
3. Balmer, P., R. Borrow, and E. Miller. 2002. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 51:717-722.
4. Barrios, C., A. R. Lussow, J. Van Embden, R. Van der Zee, R. Rappuoli, P. Costantino, J. A. Louis, P. H. Lambert, and G. Del Giudice. 1992. Mycobacterial heat-shock proteins as carrier molecules. II. The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guerin priming. Eur. J. Immunol. 22:1365-1372.
5. Carlone, G. M., C. E. Frasch, G. R. Siber, S. Quataert, L. L. Gheesling, S. H. Turner, B. D. Plikaytis, L. O. Helsel, W. E. DeWitt, W. F. Bibb, B. Swaminatban, G. Arakere, C. Thompson, D. Phipps, D. Madore, and C. V. Broome. 1992. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 30:154-159.
6. Costantino, P., F. Norelli, A. Giannozzi, S. D'Ascenzi, A. Bartoloni, S. Kaur, D. Tang, R. Seid, S. Viti, R. Paffetti, M. Bigio, C. Pennatini, G. Averani, V. Guarnieri, E. Gallo, N. Ravenscroft, C. Lazzeroni, R. Rappuoli, and C. Ceccarini. 1999. Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines. Vaccine 17:1251-1263.
7. Del Giudice, G. 1992. New carriers and adjuvants in the development of vaccines. Curr. Opin. Immunol. 4:454-459.
8. Diethelm-Okita, B. M., D. K. Okita, L. Banaszak, and B. M. Conti-Fine. 2000. Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins. J. Infect. Dis. 181:1001-1009.
9. Etlinger, H. M., D. Gillessen, H. W. Lahm, H. Matile, H. J. Schonfeld, and A. Trzeciak. 1990. Use of prior vaccinations for the development of new vaccines. Science 249:423-425.
10. Falugi, F., R. Petracca, M. Mariani, E. Luzzi, S. Mancianti, V. Carinci, M. L. Melli, O. Finco, A. Wack, A. Di Tommaso, M. T. De Magistris, P. Costantino, G. Del Giudice, S. Abrignani, R. Rappuoli, and G. Grandi. 2001. Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines. Eur. J. Immunol. 31:3816-3824.
11. Fattom, A., Y. H. Cho, C. Chu, S. Fuller, L. Fries, and R. Naso. 1999. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine 17:126-133.
12. Granoff, D. M., S. E. Maslanka, G. M. Carlone, B. D. Plikaytis, G. F. Santos, A. Mokatrin, and H. V. Raff. 1998. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin. Diagn. Lab. Immunol. 5:479-485.
13. Keitel, W. A., K. E. Kester, R. L. Atmar, A. C. White, N. H. Bond, C. A. Holland, U. Krzych, D. R. Palmer, A. Egan, C. Diggs, W. R. Ballou, B. F. Hall, and D. Kaslow. 1999. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. Vaccine 18:531-539.
14. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. J. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. N. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. A. M. Peeters, S. Quataert, J. Y. Tai, G. M. Carlone, and the Multilaboratory Study Group. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
15. McVernon, J., J. MacLennan, E. Clutterbuck, J. Buttery, and E. R. Moxon. 2003. Effect of infant immunisation with meningococcus serogroup C-CRM(197) conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children. Vaccine 21:2573-2579.
16. Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:302-317.
17. Svennerholm, L. 1957. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochem. Biophys. Acta 24:604-611.
18. Valmori, D., A. Pessi, E. Bianchi, and G. Corradin. 1992. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. 149:717-721.
19. Wuorimaa, T., and H. Kayhty. 2002. Current state of pneumococcal vaccines. Scand. J. Immunol. 56:111-129.